Therapeutic Lipidology

Chapter 1. History of Lipidology.- Chapter 2. Atherogenesis and Vascular Biology.- Chapter 3. Genetic Disorders of Lipoprotein Metabolism.- Chapter 4. Cardiovascular Genomics.- Chapter 5. Epidemiology of Atherosclerotic Cardiovascular Disease.- Chapter 6. Comparison of 2018 AHA-ACC Multi-Society Cholesterol Guidelines with 2013 ACC-AHA Cholesterol Guidelines.- Chapter 7. The Low-Density Lipoprotein Cholesterol Hypothesis: An Update.- Chapter 8. Triglyceride-rich Lipoprotein Cholesterol (Remnant Cholesterol) as a Therapeutic Target for Cardiovascular Disease Risk.- Chapter 9. Medical Nutrition Therapy for Lipid and Lipoprotein Disorders.- Chapter 10. Nutraceuticals and Lipid Management.- Chapter 11. Pharmacology of Statins.- Chapter 12. Management of Statin Intolerance.- Chapter 13. Intestinally Active Therapies for Hypercholesterolemia: Ezetimibe, Bile Acid Resins and Plant Sterols.- Chapter 14. Proprotein Convertase Subtilisin/Kexin Type 9: Functional Role in Lipid Metabolism and its Therapeutic Inhibition.- Chapter 15. Management of Hypertriglyceridemia (Including Fibrates and n-3 Fatty Acids).- Chapter 16. Pathophysiology and Management of Dyslipidemias Associated with Insulin-resistant States.- Chapter 17. Therapeutic Management of Obesity.- Chapter 18. High Density Lipoproteins.- Chapter 19. Lipoprotein (a): Principles from Bench to Bedside.- Chapter 20. Management of Homozygous Familial Hypercholesterolemia.- Chapter 21. Lysosomal Acid Lipase Deficiency.- Chapter 22. Lipodystrophies.- Chapter 23. HIV and Dyslipidemia.- Chapter 24. Cardiovascular Disease in Women: Focus on Lipid Management.- Chapter 25. Management of Dyslipidemia in the Elderly.- Chapter 26. Management of Dyslipidemia in Children.- Chapter 27. Lipoprotein Subfractions in Clinical Practice.- Chapter 28. Ion Mobility Lipoprotein Analysis.- Chapter 29. How ApoB Measurements Could Improve Prevention of Cardiovascular Disease.- Chapter 30. C-reactive Protein and Other Inflammatory Markers in Cardiovascular Disease; Inflammatory Disorders and Atherosclerosis.- Chapter 31. Coronary Artery Calcium and CT Angiography.- Chapter 32. The Clinical Use of Ultrasound for Atherosclerosis Imaging.- Chapter 33. Emerging Therapies for Regulating Dyslipidemias and Atherosclerosis.- Chapter 34. The Allied Health Professional's Role in the Management of Dyslipidemia and Accreditation Council for Clinical Lipidology Certification Program.- Chapter 35. The American Board of Clinical Lipidology Physician Certification Program.